References
- Sussman N. Biological therapies. In: Sadock BJ, Sadock VA, Ruiz P, eds. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2009:2965–3334.
- Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U; Levetiracetam N01057 Study Group. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007; 69:1751.
- Delanty N, Jones J, Tonner F. Adjunctive levetiracetam in children adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. Epilepsia 2012; 53:111–119.
- Zona C, Niespodzianny I, Marchetti C, Klitgaard H, Bernardi G, Margineanu DG. Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2 + currents. Seizure 2001; 10:279–286.
- KEPPRA label information: http://www.keppraxr.com/utilities/pi.aspx.
- Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Heard SE; American Association of Poison Control Centers. 2007 annual report of the American association of poison control centers’ national poison data system (NPDS): 25th annual report. Clin Toxicol 2008; 46:927–1057 [Poison Control Center Activity Report. CPCS 2012. (Internal document)].
- Mowry JB, Spyker DA, Cantilena LR, Bailey JE, Ford M. 2012 annual report of the American association of poison control centers’ national poison data system (NPDS): 30th annual report. Clin Toxicol 2013; 51:949–1229.
- DeSmedt T, Raedt R, Vonck K, Boon P. Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug. CNS Drug Rev 2007; 13:57–78.
- Bodmer M, Monte A, Kokko J, Yin S. Safety of non-therapeutic levetiracetam ingestions – a poison center based study. Pharmacoepidemiol Drug Saf 2011; 20:366–369.
- Glauser TA, Pellock JM, Bebin EM, Fountain NB, Ritter FJ, Jensen CM, Shields WD. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Epilepsia 2002; 43:518–524.
- Awaad Y. Accidental overdosage of levetiracetam in two children caused no side effects. Epilepsy Behav 2007; 11:247.
- Chayasirisobhon S, Chayasirisobhon W, Tsay C. Acute levetiracetam overdose presented with mild adverse events. Acta Neurologica Taiwanica 2010; 19:292–295.
- Barrueto F, Williams K, Howland MA, Hoffman RS, Nelson LS. A case of levetiracetam (Keppra®) poisoning with clinical and toxicokinetic data. J Toxicol 2002; 40:881–884.